Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Rang în acțiuni #31255
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Preț acțiune
$0.39
Capitalizare de piață
$13.79M
Schimbare (1 zi)
-13.53%
Schimbare (1 an)
-68.80%
Țară
IL
Tranzacționează NeuroSense Therapeutics Ltd. (NRSN)

Categorie

Istoricul spliturilor pentru NeuroSense Therapeutics Ltd. (NRSN)
Acțiunea NeuroSense Therapeutics Ltd. (simbol: NRSN) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 18, 2026.
O acțiune NRSN cumpărată înainte de Aug 18, 2026 este echivalentă astăzi cu 0 acțiuni NRSN.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE